Navigating CVS Caremark/Zinc Formulary Changes for DOACs
Good news! CVS will be reinstating apixaban to their formulary starting July 1, 2022. Stay tuned for more details.
CVS Caremark/Zinc has changed several formularies for commercial health plans, restricting anticoagulants to only rivaroxaban and warfarin. Clinicians are advised to proactively identify affected patients under their care and take steps to assure uninterrupted access to appropriate anticoagulation therapy.
Click here for more information on navigating the process.
The Inclusion, Diversity, Equity, and Allyship (IDEA) Initiative was established to address systemic racism and the resulting health disparities. Through this Initiative, the AC Forum will work to increase awareness and promote diversity in our leadership, membership, and programming.
Our initiatives include a webinar series, educational tools and resources, as well as scholarships to our conference and Boot Camp programs.
Learn More About Health Disparities and the IDEA Initiative.
Featured Webinar: Understanding the Social Determinants of Health
Could I Have Stopped a Stroke?
Join members of the AC Forum IDEA Initiative as they discuss how an understanding of the social determinants of health can inform how practitioners engage with patients and introduce a new AC Forum Rapid Resource on this important topic.
In this quick highlight video, learn how health disparities impact a patient’s access to quality health care and anticoagulation therapy.
Rapid Resource: Social Determinants of Health & Patient Care
This resource provides a brief overview the social determinants of health and highlights actions practitioners can incorporate into their practice to address health disparities.
News & Announcements:
Unexplained Arterial Thrombosis: Approach to Diagnosis and Treatment
July 20, 2022 @ 12:00 PM ET
Joined by the lead author of this important publication, we will discuss a structured approach to the diagnosis of unexplained arterial thrombosis, highlighting the evolution of management over the past five years. Topics will include dual-pathway inhibition, antithrombotic therapy selection in embolic stroke of undetermined source and left ventricular thrombus, the role of patent foramen ovale closure, and the thrombotic potential of COVID-19 infection and vaccination.
Jori May, MD
Arthur L. Allen, PharmD, CACP
Deborah Siegal MD, MSc, FRCPC
Andrea Van Beek, RN, DNP, AGPCNP-BC
We are pleased to provide 1.0 hours enduring accreditation for physicians, pharmacists, nurses, and pharmacy technicians!
ASHP Podcast: VTE Prophylaxis in the Medically Ill: Extending the Conversation, Part 3
In this podcast clip, AC Forum President Dr. Allison Burnett highlights the importance of anticoagulation stewardship, a key step in moving the needle on improving the safe and effective use of anticoagulants.
Listen to the full Podcast.
Practitioner's Guide for Improving Oral Anticoagulant Use, Online CE from the FDA (CE), June 2020
Free 1-hour course from the FDA on all the fundamental aspects of oral anticoagulation management including overviews of disease state & risk assessment, warfarin, DOACs, DDIs and patient issues such as compliance & joint decision-making; slides and transcript available for download; 1 hour of continuing education credit is available for physicians, nurses & pharmacists until 6/1/23.
View Course Here
FDA-funded Anticoagulation Stewardship Guide
Download our new FDA-funded release, Core
Elements of the Anticoagulation Stewardship Program, which outlines systemic protocols
designed to improve the safety and quality of care for patients and reduce the adverse drug effects related
to anticoagulant medications.